Page 15 - Jurnal Farmasi Klinik Vol 4 No 1

Jurnal Farmasi Klinik Best Practice Volume 4 No 1

Daftar Pustaka retrospektif Januari 2014-

A. Samani, R. B. (2022). Desember 2018. Jurnal Kesehatan

Glomerular filtration rate Reproduksi , Vol 7 No 2.
estimation for carboplatin
Deborah K. Armstrong, R. D.-G. (2021).
dosing in patients with
Ovarian Cancer, Version 2.2020.
gynecological cancers.
nccn clinical practice guidelines
Elsevier, 7 (2).
in oncology, Volume 19 Issue 2.

Alfia Nursetiani, E. H. (2020).
Diedra, L. B. (2021). Drug Information
identifikasi persentase
Handbook for Oncology. United
kelengkapan resep di salah
states: Lexicomp.
satu rumah sakit di kota

bandung. Farmaka, Volume Globacan. (2022). Statistics at Glance
18 Nomor 2. (Global Cancer Observatory).
International Agency for Research
C. Marth, D. R. (2017). Front-line
on Cancer .
therapy of advanced
epithelial ovarian cancer: Graziele Fonseca de Sousa, S. R. (2014).

standard treatment. Annals Carboplatin: molecular
of Oncology 28, mechanisms of action associated

(Supplement 8): 36–39. with chemoresistance. Brazilian
Journal of Pharmaceutical
Choery Novitasari, ,. A. (2020).
Science, vol. 50 4.
Perbandingan Angka

Ketahanan Hidup Penderita Julie M. Akin, J. A. (2014). Cancer
Kanker Ovarium yang Chemotherapy Update : Paclitaxel

Mendapat Terapi Regimen and Carboplatin (TC) Regimen for

Kemoterapi Paclitaxel- Ovarian Cancer. Hospital
Carboplatin dan Pharmacy , 49(5):425–431.

Cyclophosphamide L R Wiseman, C. M. (1998). Paclitaxel.
Adiamycin-Cisplatin di An update of its use in the

RSUP Dr.Sardjito: Studi treatment of metastatic breast

https://jfklin.rsupfatmawati.co.id/jfklin 14